Zhejiang Xinguang Pharmaceutical Co., Ltd.
SZSE:300519.SZ
15.16 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 543.946 | 622.03 | 593.668 | 591.848 | 407.353 | 406.49 | 376.54 | 336.633 | 175.362 | 122.62 | 101.308 | 81.515 | 61.762 |
| Short Term Investments
| 155 | 115 | 125 | 85 | 218 | 178 | 168 | 150 | -1.402 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 698.946 | 737.03 | 718.668 | 676.848 | 625.353 | 406.49 | 376.54 | 336.633 | 175.362 | 122.62 | 101.308 | 81.515 | 61.762 |
| Net Receivables
| 10.737 | 28.072 | 20.066 | 22.834 | 23.814 | 22.319 | 32.618 | 41.546 | 39.291 | 46.197 | 33.31 | 24.811 | 20.584 |
| Inventory
| 71.419 | 46.147 | 46.762 | 42.922 | 49.235 | 55.004 | 43.273 | 40.979 | 30.662 | 27.994 | 28.375 | 28.738 | 36.379 |
| Other Current Assets
| 1.46 | 1.014 | 0.42 | 0.292 | 0.005 | 178.365 | 170.708 | 151.699 | 0.188 | 0.551 | 0.092 | 0.05 | 0.672 |
| Total Current Assets
| 785.168 | 812.263 | 785.915 | 742.895 | 698.408 | 662.178 | 623.14 | 570.857 | 245.504 | 197.361 | 163.085 | 135.115 | 119.397 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 115.472 | 114.882 | 114.675 | 112.842 | 124.467 | 123.575 | 113.918 | 90.542 | 75.415 | 65.316 | 48.812 | 47.467 | 56.137 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 8.167 | 9.283 | 10.414 | 11.545 | 12.675 | 9.603 | 9.832 | 10.139 | 10.24 | 10.524 | 10.808 | 11.092 | 18.399 |
| Goodwill and Intangible Assets
| 8.167 | 9.283 | 10.414 | 11.545 | 12.675 | 9.603 | 9.832 | 10.139 | 10.24 | 10.524 | 10.808 | 11.092 | 18.399 |
| Long Term Investments
| 21.396 | -94.628 | -104.459 | -62.315 | -193.132 | 26.776 | 27.712 | 28.925 | 31.245 | 27.996 | 21.575 | 0 | 0 |
| Tax Assets
| 0.203 | 0.933 | 0.822 | 0.772 | 0.654 | 0.368 | 0.446 | 0.488 | 0.466 | 0.348 | 0.278 | 0.194 | 0.111 |
| Other Non-Current Assets
| 0 | 115.026 | 125.037 | 85.048 | 218.058 | 0 | 0 | 0 | 0 | 1.551 | 1.7 | 23.57 | 25.308 |
| Total Non-Current Assets
| 145.237 | 145.496 | 146.489 | 147.89 | 162.723 | 160.322 | 151.908 | 130.094 | 117.366 | 105.735 | 83.174 | 82.323 | 99.956 |
| Total Assets
| 930.406 | 957.759 | 932.404 | 890.786 | 861.131 | 822.5 | 775.047 | 700.951 | 362.87 | 303.096 | 246.259 | 217.438 | 219.352 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 63.876 | 56.747 | 56.115 | 36.326 | 35.391 | 46.012 | 42.042 | 31.957 | 24.125 | 22.35 | 24.584 | 44.085 | 51.449 |
| Short Term Debt
| -0.157 | -0.145 | -0.088 | -0.205 | -0.19 | -1.572 | -0.129 | -0.638 | 1 | 1 | 3 | 22 | 50 |
| Tax Payables
| 4.766 | 23.03 | 11.305 | 8.904 | 7.665 | 6.037 | 10.804 | 11.986 | 13.319 | 14.194 | 9.528 | 5.735 | 9.168 |
| Deferred Revenue
| 0.157 | 0.145 | 0.088 | 0.205 | 0.19 | 1.572 | 0.129 | 0.638 | 16.553 | 19.176 | 12.426 | 6.364 | 10.769 |
| Other Current Liabilities
| 13.204 | 31.621 | 19.107 | 15.986 | 14.541 | 12.055 | 15.867 | 16.997 | 0.017 | 0 | 0.352 | 0.19 | 0.146 |
| Total Current Liabilities
| 77.08 | 88.368 | 75.222 | 52.312 | 49.933 | 58.066 | 57.908 | 48.953 | 41.694 | 42.527 | 40.362 | 72.639 | 112.365 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 2.362 | 2.362 | 2.362 | 2.362 | 2.362 | 2.362 | 2.362 | 2.362 | 2.362 |
| Deferred Revenue Non-Current
| 6.842 | 7.708 | 8.151 | 8.78 | 8.697 | 8.395 | 8.455 | 8.515 | 8.575 | 8.6 | 1.2 | 0.426 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0.426 | 0.452 | 0.389 | 0.429 | 0.416 | 0.513 | 0.656 | 0.887 | 0.61 | 0.367 | 0.388 | 0.305 |
| Other Non-Current Liabilities
| 2.362 | 2.362 | 2.362 | 2.362 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 9.205 | 10.497 | 10.965 | 11.531 | 11.488 | 11.173 | 11.33 | 11.533 | 11.824 | 11.572 | 3.929 | 3.176 | 2.667 |
| Total Liabilities
| 86.285 | 98.865 | 86.187 | 63.843 | 61.42 | 69.24 | 69.238 | 60.487 | 53.518 | 54.099 | 44.291 | 75.815 | 115.032 |
| Equity: | |||||||||||||
| Preferred Stock
| 111.923 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 160 | 160 | 160 | 160 | 160 | 160 | 160 | 80 | 60 | 60 | 60 | 60 | 15 |
| Retained Earnings
| 407.623 | 429.692 | 427.513 | 420 | 402.441 | 365.451 | 326.254 | 270.711 | 163.648 | 116.742 | 81.656 | 28.434 | 77.81 |
| Accumulated Other Comprehensive Income/Loss
| 3.285 | 107.914 | 97.415 | 85.654 | 75.98 | 66.52 | 58.266 | 48.464 | 37.875 | 3.455 | 2.078 | 0 | 0 |
| Other Total Stockholders Equity
| 161.289 | 161.289 | 161.289 | 161.289 | 161.289 | 161.289 | 161.289 | 241.289 | 47.829 | 68.8 | 58.235 | 53.189 | 9.5 |
| Total Shareholders Equity
| 844.121 | 858.895 | 846.217 | 826.943 | 799.71 | 753.26 | 705.809 | 640.464 | 309.352 | 248.997 | 201.968 | 141.623 | 102.31 |
| Total Equity
| 844.121 | 858.895 | 846.217 | 826.943 | 799.71 | 753.26 | 705.809 | 640.464 | 309.352 | 248.997 | 201.968 | 141.623 | 104.321 |
| Total Liabilities & Shareholders Equity
| 930.406 | 957.759 | 932.404 | 890.786 | 861.131 | 822.5 | 775.047 | 700.951 | 362.87 | 303.096 | 246.259 | 217.438 | 219.352 |